Director's Dealing • Nov 17, 2022
Director's Dealing
Open in ViewerOpens in native device viewer
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Louise Gjelstrup | ||
| 2. | Reason for the notification | |||
| a) | Position/status | Employee elected member of the Board of Directors of Zealand Pharma A/S | ||
| b) | Initial notification/Amend ment |
Initial notification | ||
| 3. | tion monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc | ||
| a) | Name | Zealand Pharma A/S, CVR-no. 20045078 |
||
| b) | LEI1 | 549300ITBB1ULBL4CZ12 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instru ment |
Shares | ||
| Identification code | DK0060257814 | |||
| b) | Nature of the transaction | Sale of Shares | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| DKK 182.657 | 525 | |||
| d) | Aggregated information - Aggregated volume - Price |
525 DKK 95,894.92 |
||
| e) | Date of the transaction | 15 November 2022 |
||
| f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.